Patient Safety Graduate Programme - UK
Patient Safety Graduate Programme - UK
Salary - £31,757 plus Bonus & Benefits Package
Make an impact, and kickstart your career.
If you are committed to helping deliver the next generation of life-changing medicines, our innovative new Patient Safety Graduate Programme could be the ideal start to your career. You will learn how Patient Safety supports clinical drug development and helps ensure the safety of our patients. You’ll grow, develop and make a difference to medicine, patients and society!
AstraZeneca is a global, science-led, patient-centred biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines for some of the world’s most serious diseases. But we’re more than a leading pharmaceutical company. At AstraZeneca, we‘re dedicated to being a Great Place to Work where you’ll be backed and encouraged to speak up, ask questions, and share ideas to push the boundaries of science and continuously learn and explore.
About Patient Safety:
Patient Safety focuses on pharmacovigilance, the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems. The importance of pharmacovigilance has been recognised worldwide because the high prevalence of medicine side effects ranks among the leading causes of morbidity and mortality. The aim and scope of pharmacovigilance is broad and also includes medication errors, counterfeit and unauthorized medicines, lack of efficacy, drug interactions, and rational prescription of medicines.
Our Patient Safety team sits in the Chief Medical Office, part of the Research & Development organisation. We operate across the enterprise and are dedicated to defining the benefit-risk profile of our medicines across their entire lifecycle, and also achieving and maintaining health authority approvals around the world.
About The Programme:
During the course of this two-year programme, you will have the opportunity to make real contributions to our projects and deliver the next generation of life-changing medicines. This involves developing proactive safety strategies that ensure the right balance between the benefits and risks of our medicines.
You will gain an understanding of pharmacovigilance activities and the key role that Patient Safety plays in clinical drug development. In collaboration with more senior scientists and physicians, you will help ensure the safety of patients who take our medicines.
Your first two months will be focussed on initial training, and introducing you to the role of pharmacovigilance in drug development, key regulations, procedures, and systems. This introduction will help embed the knowledge and key skills you need to succeed.
You will then tackle a range of exciting placements in early and late stage drug development, supported, guided and supervised by your placement ‘buddy’. As you progress you’ll get involved in clinical drug development, and will learn from colleagues across aligned functions (e.g. Translational Medicine, Clinical Development, Regulatory).
You can expect to be involved in a number of core activities, such as:
- Evaluating possible side effects (adverse events) and other safety information, to characterise and manage the safety profile of drugs
- Updating product safety information to support prescribing decisions with patients
- Applying key pharmacovigilance guidelines in the production of core documents
- Developing responses to regulatory agency (e.g. US FDA, UK MHRA, EU EMA) enquiries
- Designing risk management activities for clinical trials and marketed use
- Provide safety contributions for regulatory agency interactions and/or when we are preparing to apply for a new licence to market a drug (known as product submission activities)
- Predicting the potential safety profile of new molecules, based on their mechanism of action and data from animal studies
- Lead pharmacovigilance activities for an early development (phase 1 or 2) product
- Contribute to process improvement activities within global Patient Safety
As part of our Patient Safety Graduates joining us in September 2023, you’ll also help shape the programme’s future direction.
- Life sciences (e.g. Biochemistry, Bioscience, Biology, Pharmacology or similar) graduates with a minimum of a 2:1 (UK) or equivalent Bachelor's or Master’s degree gained in 2022, or to be gained by September 2023
- A passion for science and a commitment to protecting patients
- Innovative thinkers with the enthusiasm and energy to match their scientific expertise
- Good inter-personal skills and a collaborative working style
- Strong critical thinking, stakeholder management, planning, organisational and time management skills
After applying you will complete an online assessment (SHL). If shortlisted, you will be invited to a virtual assessment day week commencing 30th January 2023.
The assessment day will help us assess your capabilities and alignment to our values, and enable you to find out more about our programme, team and organisation.
Ready for an exciting, rewarding challenge? Apply today!
Advert Opens: 21st September 2022
Advert Closes: 6th November 2022
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorisation and employment eligibility verification requirements.